Internal Medicine Doctors in Zachary, LA Accepting Medicare

6 Internal Medicine doctors found. Showing 1 - 6

Dr. Narayanan Deepak Karayil Thekkoott, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6550 Main Street, Ste. 1000, Zachary, LA 70791 Phone: 225-654-1559    Fax: 225-654-6212

Clayton G Brown, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 4727 W Park Dr Ste A, Zachary, LA 70791 Phone: 225-654-0027    Fax: 225-654-0052

Dr. Babu Jasti, M.D. Internal Medicine - Interventional Cardiology Medicare: Accepting Medicare Assignments Practice Location: 6550 Main St, Ste. 1000, Zachary, LA 70791 Phone: 225-654-1559    Fax: 225-654-6212

Charles Allen Thompson, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6550 Main Street, Suite 1000, Zachary, LA 70791 Phone: 225-654-1559    Fax: 225-654-6212

Amanda Riddell Lea, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2335 Church St, Suite E, Zachary, LA 70791 Phone: 225-654-3607    Fax: 225-658-2262

Mr. Abdullah Bin Munir, M.D. Internal Medicine - Interventional Cardiology Medicare: Medicare Enrolled Practice Location: 6550 Main St Ste 1000, Zachary, LA 70791 Phone: 225-654-1559    Fax: 225-654-6212

News Archive

Domestic violence may affect mothers' breastfeeding practices in developing countries

Mothers who have suffered from domestic violence are substantially less likely to follow recommended breastfeeding practices in low to middle-income countries, a new study shows.

Elevated blood sugar levels and diabetes are risk factors for developing several types of cancer and mortality

The researchers followed over 1.2 million Koreans for 10 years, tracking new cancer cases and deaths from cancer. Study participants with diabetes, as well as those without diabetes and higher fasting blood sugar levels, were more likely to develop cancer or to die from cancer.

Positive CHMP opinion recommends RELISTOR for treatment of opioid-induced constipation

Valeant Pharmaceuticals International, Inc. and Progenics Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending a new indication for RELISTOR (methylnaltrexone bromide) Subcutaneous Injection for the treatment of opioid-induced constipation (OIC) when response to laxative therapy has not been sufficient in adult patients, aged 18 years and older.

Gilead Sciences announces positive results from LDV/SOF phase 2 studies on HCV infection

Gilead Sciences, Inc. (Nasdaq: GILD) today announced data from two Phase 2 studies evaluating investigational all-oral regimens containing the nucleotide analog polymerase inhibitor sofosbuvir (SOF) for the treatment of chronic hepatitis C virus (HCV) infection.

Read more Medical News

› Verified 6 days ago